235
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Control of drug release by incorporation of sorbitol or mannitol in microcrystalline-cellulose-based pellets prepared by extrusion-spheronization

, &
Pages 626-635 | Received 23 Jul 2009, Accepted 14 Oct 2009, Published online: 11 Feb 2010

References

  • Fielden KE, Newton JM, Rowe RC. The influence of lactose particle-size on spheronization of extrudate processed by a ram extruder. Int J Pharm 1992;81:205–224.
  • Shah RD, Kabadi M, Pope DG, Augsburger LL. Physicomechanical characterization of the extrusion-spheronization process. 2. Rheological determinants for successful extrusion and spheronization. Pharm Res 1995;12:496–507.
  • Pinto JF, Buckton G, Newton JM. The influence of 4 selected processing and formulation factors on the production of spheres by extrusion and spheronization. Int J Pharm 1992;83:187–196.
  • Millili GP, Schwartz JB. The strength of microcrystalline cellulose pellets – the effect of granulating with water ethanol mixtures. Drug Dev Ind Pharm 1990;16:1411–1426.
  • Souto C, Rodriguez A, Parajes S, Martinez-Pacheco R. A comparative study of the utility of two superdisintegrants in microcrystalline cellulose pellets prepared by extrusion-spheronization. Eur J Pharm Biopharm 2005;61:94–99.
  • Vervaet C, Baert L, Remon JP. Enhancement of in-vitro drug-release by using polyethylene-glycol-400 and peg-40 hydrogenated castor-oil in pellets made by extrusion/spheronisation. Int J Pharm 1994;108:207–212.
  • Schroder M, Kleinebudde P. Influence of formulation parameters on dissolution of propyphenazone pellets. Eur J Pharm Biopharm 1995;41:382–387.
  • Lindner H, Kleinebudde P. Use of powdered cellulose for the production of pellets by extrusion spheronization. J Pharm Pharmacol 1994;46:2–7.
  • Alvarez L, Concheiro A, Gomez-Amoza JL, Souto C, Martinez-Pacheco R. Powdered cellulose as excipient for extrusion-spheronization pellets of a cohesive hydrophobic drug. Eur J Pharm Biopharm 2003;55:291–295.
  • Tho I, Sande SA, Kleinebudde P. Disintegrating pellets from a water-insoluble pectin derivative produced by extrusion/spheronisation. Eur J Pharm Biopharm 2003;56:371–380.
  • Thommes M, Kleinebudde P. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler. Eur J Pharm Biopharm 2006;63:59–67.
  • Dukic-Ott A, Remon JP, Foreman P, Vervaet C. Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation. Eur J Pharm Biopharm 2007;67:715–724.
  • Howard MA, Neau SH, Sack MJ. PEO and MPEG in high drug load extruded and spheronized beads that are devoid of MCC. Int J Pharm 2006;307:66–76.
  • Ku CC, Joshi YM, Bergum JS, Jain NB. Bead manufacture by extrusion spheronization – a statistical design for process optimization. Drug Dev Ind Pharm 1993;19:1505–1519.
  • Sousa JJ, Sousa A, Podczeck F, Newton JM. Factors influencing the physical characteristics of pellets obtained by extrusion-spheronization. Int J Pharm 2002;232:91–106.
  • Fielden KE, Newton JM, Rowe RC. The effect of lactose particle-size on the extrusion properties of microcrystalline cellulose-lactose mixtures. J Pharm Pharmacol 1989;41:217–221.
  • Fielden KE, Newton JM, Rowe RC. The influence of moisture-content on spheronization of extrudate processed by a ram extruder. Int J Pharm 1993;97:79–92.
  • Dyer AM, Khan KA, Aulton ME. Effect of the drying method on the mechanical and drug-release properties of pellets prepared by extrusion-spheronization. Drug Dev Ind Pharm 1994;20:3045–3068.
  • Baert L, Fanara D, Remon JP, Massart D. Correlation of extrusion forces, raw-materials and sphere characteristics. J Pharm Pharmacol 1992;44:676–678.
  • Wan LSC, Heng PWS, Liew CV. Spheronization conditions on spheroid shape and size. Int J Pharm 1993;96:59–65.
  • Iyer RM, Augsburger LL, Pope DG, Shah RD. Extrusion/spheronization-effect of moisture content and spheronization time on pellet characteristics. Pharm Dev Tech 1996;1:325–331.
  • Hasznos L. The effect of drug load, type of microcrystalline cellulose and lactose particle size on selected pellet characteristics. Pharmazie 1998;53:423.
  • Sandri G, Maria CB, Ferrari F, Rossi S, Caramella C. Differentiating factors between oral fast-dissolving technologies. Am J Drug Deliv 2006;4:249–262.
  • Yalkowsky SH, He Y. Handbook of aqueous solubility data. Boca Raton: CRC Press; 2003.
  • Dukic A, Mens R, Adriaensens P, et al. Development of starch-based pellets via extrusion/spheronisation. Eur J Pharm Biopharm 2007;66:83–94.
  • Exner HE, Linck E. Image analysis for characterization of size-distribution and shape-distribution of lead powders. Powder Metall Int 1977;9:131–133.
  • Fayed FM, Otten L. Handbook of powder science and technology. New York: Van Nostrand Reinhold; 1984.
  • Svarovsky L. Powder testing guide: Methods of measuring the physical properties of bulk powders. London: Elsevier Applied Science; 1987.
  • Khan KA, Rhodes CT. Effect of compaction pressure on dissolution efficiency of some direct compression systems. Pharm Acta Helv 1972;47:594–607.
  • Dokoumetzidis A, Papadopoulou V, Macheras P. Analysis of dissolution data using modified versions of Noyes-Whitney equation and the Weibull Function. Pharm Res 2006;23:256–261.
  • Alvarez L, Concheiro A, Gomez-Amoza JL, Souto C, Martinez-Pacheco R. Effect of micro crystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization. Drug Dev Ind Pharm 2002;28:451–456.
  • Sinha VR, Kumria R, Agrawal MK. Influence of formulation and excipient variables on the pellet properties prepared by extrusion spheronization. Curr Drug Deliv 2005;2:1–8.
  • Lustig-Gustafsson C, Johal HK, Podczeck F, Newton JM. The influence of water content and drug solubility on the formulation of pellets by extrusion and spheronisation. Eur J Pharm Sci 1999;8:147–152.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.